Catalyst Wire Dossier Catalyst Wire Dossier

Pegaferonae

Pegylated Interferon Alpha-2a
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pegaferonae, covering 2009-01-21 to 2009-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis C [Phase 3]

See pricing